Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
the description says "granular" form. Is Vascepa granular or powder form?
BP BO
I see lots of comments about this , but honestly which BP would be best to purchase AMRN? Anyone with comments or answers on this?
Regardless , there was relatively little volume yesterday and I did add on a few shares yesterday at $0.83. If it was that bad, the volume of selling should have been at least $15-20 million shares, It was not.
How many times are you going to rehash the same monologue about Germany? I am done reading all of these supposedly explanation why Germany is not on board.
Yes all that is published on AMRN website, yet I haven't seen anything posted or published by MarketWatch or Briefing.com, etc..
Ok they have announced the results of the board meeting but did not publish it on the market? JUST wondering why?
I tend to agree with Rosemountbomber comments & yours. Just wondering why noone is commenting about Saudi Arabia market (approved last year). What's the catch there?? any activity?
No idea. But I do see that the XBI went down 10% over the past month.
I feel the same. That is why I bought 1,000 shares at )66 c & $0.71 c earlier last year. (500 & 500). So if we get another dip below 0.90 I might get a few 1000 shares but I already have so much (versus the rest of my portfolio) that I am cautious bout adding more. Just waiting for price to go above $2 to $3 as I have been in the red (over 55% at times) for the past 4 years. I never buy & sell short term, never short either, just hold.
I believe once their sales jump above $100K per QTR, their inventory problem will be solved. The extension of the patent in Europe is certainly good news.
Don't understand why everyone is always talking about shorts. AMRN averages about 14 million short shares on a monthly basis which is about 3.5% of the total shares outstanding.
I don't really think this justifies or accounts for the share price to be that low, this opinion really does not hold any water. Just browse all the small to medium range Pharma stocks and most of them have much higher short %.
On the other hand, the fact that AMRN has a relatively low % of Institutional holdings ( 25%) does definitely affect the way the stock price is moving.
I'll believe it when I see it. Until then, let's first see what the judges rendered comments are after today's exchange.
I think presently the stock is not moving up due to :
1- lack of clarification on the 4th Qtr 2023 reporting.
2- lack of info % of current institutional share ownership of the company, Found it difficult to find detailed info on 13D/G filings anywhere as of now.
3- Investors are all waiting to see 1st Qtr 2024 results & also the final Year end report for the merger.
4- Most brokers don't have current Year end data posted for the year end 2023, as a matter of fact, ETRADE has zero financial info posted on the company.
I hope by June we'll have a better picture on the company, currently listed as a Low/Medium risk by Morningstar. We shall see, but the oversupply of lithium as mentioned by others is only temporary as the EV market expands. Not to forget ALTM is very diversified & has products used in several different markets(Polymers, grease, aerospace, pharmaceutical & agrochemical, industrial use).
Headed much lower
Yes they basically make a #JE and take the 1.5 Million Additional Paid in Capital and apply it against the net Loss of $1,586 million loss, Then, since have approx 450 Miilion (cash+ net AR) against total liability of 280 million. So that is cutting it close in view that they would still show $86 million loss on the books . Would be better or I should say "better received by the Regulators", if the company had a 2 to 1 ratio Cash/liability
Thank you for your response. Although, if you look the compensation of Executives & Directors as shown on their publication March 12, 2024 ( NPS_561609), you can see that most of their bonuses & shares issued are non restricted and therefore equivalent to cash. I am critical of that method of allocation of shares for the following reasons:
1- The calculation of their % performance as listed in that publication seems way overvalued based on actual results for 2023. ( see pages 52, 57 & page 69 for directors in NPS_561609)
2- Looking at past history this compensation method for Execs &* Directors over the past 5 years has not resulted in the company achieving any substantail or any concrete results.
I would tend to agree more on a compensation based on issuing share starting at $2.00 price (as mentioned by others on this board) . This would set up a real goal to be achieved. Then when the price goes to $3.00 for a period of a year, you augment the % of compensation, etc. I am quiet certain that would in turn incite these Executive & Directors to become more productive & grow sales at a faster pace. Otherwise you basically are rewarding them for the current value & performance of the company or (no performance) as is.
For the record, could you please send us a copy of your 13F filing. Thank You.
I tend to partially disagree. partially with your views regarding the future. All the excutives & directors are going to issue themselves millions ( maybe even around 18 million shares annually over the next 3 years ( here goes the 50 million shares buyback???) & options when the price is around $0.80 per shares. With their Executives compensation around $11 million annually & each of their directors (x8) receiving over 1 million annually ($8 million) not to mention their emplotees getting an average compensation of $162 K per year, you are going to need lots more revenue t cover that & it is very doubtful their sales will improve at all during the current year.
All in all I am voting against this proxy.
Well I see a lot of different opinions & thinking about this 50 million shares buyback. All I can say is: If the prices stays under $1.00 for the next 22 days, we get delisted again. So if that's the case I will be voting no on all the proposals. Because i can see all these key employees & especially the directors getinng paid huge amounts & not accomplishing anything over the past year & getting even much more over the next few years. Moreover one must recognize that Denner is using AMRN to compensate the majotity of the Sarissa Corp and that suits him very well. Therefore unless we get some news on some additional European approval & launch within the next 22 days I am voting against. Besides bringing cost under control, not much else has happened over the past year, and the way it looks according to Holt they do not expect much to happen until the late part of 2025, if that.
Yes it does say 1.5 m . just read the proxy
You mean reconcile to the 1.3 million mentioned in the proxy, right?
just look atthe most current financial statement reported for the last quarter. Then when they publish the 1st qtr 2024, you'll get the new figures. All these different figures reported by Yahoo, Schwab, Etrade, Fidelity really don't matter.
Curious to know who bought that 6,967,077 block Trade at 16.37 pm on Feb 23, 2024
I think so as well
Earnings were out today. according to Yahoo earnings report: ALTM results were better than expected:
Symbol / Company Earnings Date PS Estimate eported EPS Surprise(%)
ALTM
Arcadium Lithium plc Feb 22, 2024, 4 PMEST 0.14 0.34 146.38
Stock closed higher on fairly high volume. Looks like there has been quiet a bit of accumulation over the
past month according to the 13 D filings as of 2/15/2024, from Whalewisdom: see below added shares:
Column1 Column2 Column3
ALLIANCEBERNSTEIN L.P. 2/14/2024 191,108
AMERIPRISE FINANCIAL INC 2/14/2024 2,950,696
AMUNDI 2/14/2024 336,938
Bank of America 2/15/2024 3,129,658
BARCLAYS PLC 2/15/2024 3,778,659
Blackrock 2/15/2024 64,640,747
BNP Paris Bas 2/14/2024 246,109
JANE STREET GROUP, LLC 2/14/2024 6,439,185
LAZARD ASSET MANAGEMENT LLC 2/14/2024 793,542
LEGAL & GENERAL GROUP PLC 2/15/2024 608,804
Millenium LLC 2/14/2024 19,960,392
SHAPIRO CAPITAL MANAGEMENT LLC 2/14/2024 1,212,424
STATE STREET CORP 2/14/2024 303,273
WALLEYE TRADING LLC 2/14/2024 468,804
CREDIT SUISSE AG/ 2/08/2024 781,692
JANUS Hendserson Group 2/14/2024 305,222
BRAGG FINANCIAL ADVISORS, INC 2/14/2024 254,097
MAN GROUP PLC 2/14/2024 502,897
SCHONFELD STRATEGIC ADVISORS LLC 2/14/2024 531,131
TWO SIGMA SECURITIES, LLC 2/14/2024 157,215
BREVAN HOWARD CAPITAL MANAGEMENT LP 2/14/2024 387,962
NORTHERN TRUST CORP 2/13/2024 561,141
TOTAL SHARES additions 108,541,696
Could we see the share price going back to the $6.00-$7.00 level soon. IMO
we shall see upon the reporting of the 1st QTR 2024 or perhaps even before
if the market price for Lithium goes back to the $20 level. this should happen when
exisitng inventories of lithium batteries among various companies like Tesla, Ford ,
etc..becomes extinguished.
Really like the way the tripdatabase works. However unless you go PRO, you are unable to access secondary & current trial & results. Great for Medical staff, etc but IMO questionable for just average investors. I guess it depends whether you want to spend $18 monthly to get the answers to your questions
I like how Amarin management is asking for questions from shareholders
Yes: except when you go to the website address: https://app.saytechnologies.com/amarin-2023-q4. and you try to sign up or login, it does not let you do it.
I agree with you both that an email & public announcement is normal practice & should happen before the release Of the year end report.
Well given that they released the preliminary towards the beginning of January (the 10th I believe) , I do not see why they have to wait until Mar 04 to release the actual earnings report, unless they want to announce something else when they report the final.
that's what shows on Yahoo earnings report Feb 14
TA, BA, DA, DAH, DAH, CC, FU. when are going to start speaking proper English?
Well:
"I am curious if this is a "back pocket" thing that Sarissa is going to use to dangle to BP's, rather than show their hand to the generics by rolling out."
if yourself can think about it, what makes you think the generics don't already know about that?
yes especially the JPM analyst who hasn't commented at all on the recent conference
yes just saw that about 6 minutes ago. it did not post until just now on the volume traded before, but Nasdaq had reported it before
according to Yahoo earnings reports, they report on Feb 14, 2024 at 2 am
That's were I am heading this summer & Tuscany & Corsica. Can/t wait
Just looking at the 200 days high chart it looks like the stock closed on 4/10/2023 at $1.38. let's see how soon we get there?
Ok I hope thjis not the case for AMRN and that it stays above $1.00 going forward
Yes Here it is according to Bloomberg article: " Nasdaq allows 180 calendar days to regain compliance by maintaining a $1 closing bid price for a minimum of 10 consecutive days during the 180-day period."
I am not so sure about the 10 days rules to stop the delisting. here is what I read
30 consecutive business days
Since early 2023, hundreds of small public companies have risked being delisted for non-compliance with Nasdaq, Inc. and NYSE American's continued listing requirements. Chief among the deficiencies has been failure to maintain at least a $1 closing bid price per share for 30 consecutive business days. As of Dec.Dec 13, 2023
Don't really know about GS being involved in shorting the stock. However I can read & according to the 13 D filing on 11/14 for Goldman Sacks : they owned 243234 shares as of the end of the 3rd qtr and they increased their position by 161,655 shares , that's an increase of 66%. In the past I saw that they had options puts & calls in large quantities but lately they have not reported any of these so I assume they are no longer in the options game. On the other hand they have not changed their "sell" rating on Amarin, so they most likely are accumulating to bring their AVG price down. Curious to see what they will show on their next 13D filing? and also if and when they will change that rating to a buy